MAGE-A4 allogeneic cell therapy (Adaptimmune)

N/A

Report date: 2025/03/20 15:47:18

Base Information

Drug NameMAGE-A4 allogeneic cell therapy (Adaptimmune)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionMelanoma-associated antigen 4 modulators
TargetsMelanoma-associated antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdaptimmune Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdaptimmune Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A